Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |